- Home
- Publications
- Publication Search
- Publication Details
Title
Alzheimer's disease
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume -, Issue -, Pages 15056
Publisher
Springer Nature
Online
2015-10-15
DOI
10.1038/nrdp.2015.56
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quality of Life in Alzheimer Disease
- (2015) Chiara Zucchella et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- APOEε2 is associated with milder clinical and pathological Alzheimer disease
- (2015) Alberto Serrano-Pozo et al. ANNALS OF NEUROLOGY
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
- (2015) Tiia Ngandu et al. LANCET
- Tau imaging: early progress and future directions
- (2015) Victor L Villemagne et al. LANCET NEUROLOGY
- Tracking Early Decline in Cognitive Function in Older Individuals at Risk for Alzheimer Disease Dementia
- (2015) Rebecca E. Amariglio et al. JAMA Neurology
- Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
- (2015) Craig Curtis et al. JAMA Neurology
- Predicting Alzheimer disease with β-amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
- (2014) Christopher C. Rowe et al. ANNALS OF NEUROLOGY
- Caregivers’ quality of life in mild and moderate dementia
- (2014) Raquel Luiza Santos et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
- (2014) Niklas Mattsson et al. BRAIN
- Developments in Tau PET Imaging
- (2014) Eduardo Rigon Zimmer et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- The Independent Contributions of Cognitive Impairment and Neuropsychiatric Symptoms to Everyday Function in Older Adults
- (2014) Lauren A. Rog et al. CLINICAL NEUROPSYCHOLOGIST
- New applications of disease genetics and pharmacogenetics to drug development
- (2014) Allen D Roses et al. CURRENT OPINION IN PHARMACOLOGY
- Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease
- (2014) Maurice W. Dysken et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Citalopram on Agitation in Alzheimer Disease
- (2014) Anton P. Porsteinsson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study
- (2014) Kevin T Ong et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
- (2014) Sam Norton et al. LANCET NEUROLOGY
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
- (2014) Ann Brinkmalm et al. Molecular Neurodegeneration
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis
- (2014) D. C. Ryman et al. NEUROLOGY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Which variable is the strongest adjusted predictor of quality of life in caregivers of patients with dementia?
- (2014) Ibrahim Abdollahpour et al. Psychogeriatrics
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
- (2014) Sebastian Palmqvist et al. JAMA Neurology
- The Preclinical Alzheimer Cognitive Composite
- (2014) Michael C. Donohue et al. JAMA Neurology
- Synergistic Effect of β-Amyloid and Neurodegeneration on Cognitive Decline in Clinically Normal Individuals
- (2014) Elizabeth C. Mormino et al. JAMA Neurology
- Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease
- (2014) Niklas Mattsson et al. Annals of Clinical and Translational Neurology
- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series
- (2013) Gabor G. Kovacs et al. ACTA NEUROPATHOLOGICA
- The incidence of Parkinson's disease in the North-East of England
- (2013) G. W. Duncan et al. AGE AND AGEING
- The future of blood-based biomarkers for Alzheimer's disease
- (2013) Kim Henriksen et al. Alzheimers & Dementia
- Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease
- (2013) Muriel Noetzli et al. CLINICAL PHARMACOKINETICS
- Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial
- (2013) Krista L. Lanctôt et al. INTERNATIONAL PSYCHOGERIATRICS
- The Role of Nutrition and Diet in Alzheimer Disease: A Systematic Review
- (2013) Rusha Shah Journal of the American Medical Directors Association
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
- (2013) Jeffrey Cummings et al. LANCET
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Ushering in the study and treatment of preclinical Alzheimer disease
- (2013) Jessica B. Langbaum et al. Nature Reviews Neurology
- Using AD biomarker research results for clinical care: A survey of ADNI investigators
- (2013) M. B. Shulman et al. NEUROLOGY
- Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
- (2013) C. M. Roe et al. NEUROLOGY
- Brain -amyloid load approaches a plateau
- (2013) C. R. Jack et al. NEUROLOGY
- Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease
- (2013) Kaj Blennow et al. NEUROPSYCHOPHARMACOLOGY
- Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
- (2013) Chris G. Parsons et al. NEUROTOXICITY RESEARCH
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in North East Scotland: The PINE study
- (2013) Robert Caslake et al. PARKINSONISM & RELATED DISORDERS
- Changes in Amyloid- and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein
- (2013) L. F. Maia et al. Science Translational Medicine
- Dominantly Inherited Alzheimer Network: facilitating research and clinical trials
- (2013) Krista L Moulder et al. Alzheimers Research & Therapy
- Incidence and Pathology of Synucleinopathies and Tauopathies Related to Parkinsonism
- (2013) Rodolfo Savica et al. JAMA Neurology
- Effectiveness of antidementia drugs in delaying Alzheimer's disease progression
- (2012) Susan D. Rountree et al. Alzheimers & Dementia
- Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints
- (2012) Argonde C. van Harten et al. Alzheimers & Dementia
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
- (2012) Henrik Zetterberg ARCHIVES OF NEUROLOGY
- Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer's Disease
- (2012) John M. Ringman et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
- (2012) Agneta Nordberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Quality of life in Alzheimer's disease: different factors associated with complementary ratings by patients and family carers
- (2012) Pascalle R. Bosboom et al. INTERNATIONAL PSYCHOGERIATRICS
- Determinants of quality of life in Alzheimer's disease: perspective of patients, informal caregivers, and professional caregivers
- (2012) Maria Gómez-Gallego et al. INTERNATIONAL PSYCHOGERIATRICS
- Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
- (2012) Eric M Reiman et al. LANCET NEUROLOGY
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Injury markers predict time to dementia in subjects with MCI and amyloid pathology
- (2012) I. A. van Rossum et al. NEUROLOGY
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
- (2012) D. S. Knopman et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Hippocampal sclerosis in advanced age: clinical and pathological features
- (2011) Peter T. Nelson et al. BRAIN
- Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
- (2011) Sudad Saman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Robust Central Reduction of Amyloid- in Humans with an Orally Available, Non-Peptidic -Secretase Inhibitor
- (2011) P. C. May et al. JOURNAL OF NEUROSCIENCE
- The role of G protein-coupled receptors in the pathology of Alzheimer's disease
- (2011) Amantha Thathiah et al. NATURE REVIEWS NEUROSCIENCE
- Management of End-Stage Dementia
- (2011) David Lussier et al. PRIMARY CARE
- Quality of life of community-residing persons with dementia based on self-rated and caregiver-rated measures
- (2011) Betty S. Black et al. QUALITY OF LIFE RESEARCH
- Testing the Right Target and Right Drug at the Right Stage
- (2011) R. A. Sperling et al. Science Translational Medicine
- Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease
- (2010) Erik Portelius et al. ACTA NEUROPATHOLOGICA
- Sertraline for the Treatment of Depression in Alzheimer Disease
- (2010) Paul B. Rosenberg et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Generic and Disease-Specific Measures of Quality of Life in Patients with Mild Alzheimer’s Disease
- (2010) Suvosree Bhattacharya et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
- (2010) Harald Hampel et al. NATURE REVIEWS DRUG DISCOVERY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- CSF biomarkers predict a more malignant outcome in Alzheimer disease
- (2010) A. K. Wallin et al. NEUROLOGY
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
- (2009) John C. Morris et al. ARCHIVES OF NEUROLOGY
- Rapid Progression from Mild Cognitive Impairment to Alzheimer’s Disease in Subjects with Elevated Levels of Tau in Cerebrospinal Fluid and the APOE ε4/ε4 Genotype
- (2009) Elin S. Blom et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
- (2009) Kathryn A Ellis et al. INTERNATIONAL PSYCHOGERIATRICS
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Elderly Patients With Dementia-Related Symptoms of Severe Agitation and Aggression
- (2009) Carl Salzman et al. JOURNAL OF CLINICAL PSYCHIATRY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau181P
- (2009) Karen Koopman et al. NEUROCHEMISTRY INTERNATIONAL
- Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization
- (2009) R. C. Petersen et al. NEUROLOGY
- Disclosure ofAPOEGenotype for Risk of Alzheimer's Disease
- (2009) Robert C. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Brain Injury Biomarker VLP-1 Is Increased in the Cerebrospinal Fluid of Alzheimer Disease Patients
- (2008) J.-M. Lee et al. CLINICAL CHEMISTRY
- apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
- (2008) Rashid Deane et al. JOURNAL OF CLINICAL INVESTIGATION
- Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
- (2008) Christopher C Rowe et al. LANCET NEUROLOGY
- Biochemical markers in persons with preclinical familial Alzheimer disease
- (2008) J. M. Ringman et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now